Eloctate (Intravenous)

Generic name:antihemophilic factor (intravenous route) [ an-tee-hee-moe-FIL-ik-FAK-tor ]
Drug class:Miscellaneous coagulation modifiers

Medically reviewed by Drugs.com. Last updated on Dec 22, 2021.

Commonly used brand name(s)

In the U.S.

• Advate
• Adynovate
• Afstyla
• Eloctate
• Esperoct
• Helixate FS
• Hemofil-M
• Hyate:C
• Jivi
• Koate DVI
• Obizur

Available Dosage Forms:

• Powder for Solution

Therapeutic Class: Antihemophilic Agent

Uses for Eloctate

Antihemophilic factor (AHF) injection is used to treat and control serious bleeding episodes in patients with a bleeding problem called hemophilia A (congenital Factor VIII deficiency). The bleeding episode may be related to an injury (trauma) or a surgical procedure. It is also used to reduce the number of bleeding episodes in patients when used regularly. AHF injection is also used to prevent bleeding during a surgical procedure.

Antihemophilic factor (AHF) is a protein that is produced naturally in the body. It helps the blood form clots to stop bleeding and prevents bleeding problems from happening as often.

Hemophilia A, also called classical hemophilia, is a condition where the body does not make enough AHF. If you do not have enough AHF and you become injured, your blood will not form clots properly. You might bleed into and damage your muscles and joints. AHF injection is given to increase the levels of AHF in the blood.

There are several different types of AHF. They are made from human blood or artificially by a man-made process (recombinant). AHF made from human blood has been treated and is not likely to contain harmful viruses, such as hepatitis B, hepatitis C, or human immunodeficiency virus (HIV), the virus that causes acquired immunodeficiency syndrome (AIDS). The man-made AHF products do not contain these viruses.

This medicine is available only with your doctor's prescription.

Before using Eloctate

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of antihemophilic factor injection in children.

No information is available on the relationship of age to the effects of Hemofil® M in the pediatric population. Safety and efficacy have not been established.

Geriatric

Although appropriate studies on the relationship of age to the effects of Advate®, Adynovate®, Eloctate™, Kogenate® FS, Kovaltry®, Novoeight®, Xyntha®, and Xyntha® Solof...